hsa-miR-221

ncRNA information

ncRNA name

hsa-miR-221

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

Yes

Biomarker application

Treatment

Upstream regulatory factors

Not available

Downstream target

PI3K/Akt

Cancer information

Cancer name

Osteosarcoma

Cancer site

Bone, Articular Cartilage

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Down

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Upregulation of miR-221 induces the malignant phenotype of human osteosarcoma whereas knockdown of miR 221 reverses this phenotype.

Tissue resource

human osteosarcoma tissues and normal adjacent tissues

human osteosarcoma cell lines SOSP-9607

human osteosarcoma cell lines SOSP-9901

Experiment

qRT-PCR,Western blot,Luciferase reporter assay


Institute

Institute of Chinese PLA of Tangdu Hospital

Country

China

Continent

Asia